BioCentury
ARTICLE | Clinical News

XM-ONE: Postmarketing study started

June 4, 2012 7:00 AM UTC

Allenex (formerly LinkMed AB) said Tulane University's Tulane Medical Center began an investigator-sponsored, prospective trial to evaluate XM-ONE before and 6 months after transplantation in about 10...